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Background: The volatile anesthetic isoflurane protects the heart from hypoxia/reperfusion (H/R) injury. However, it
is still incompletely understood whether isoflurane exerts its protective role through preventing mitochondrial
permeability transition pore (MPTP) opening.
Methods: Primary cultured cardiocytes were exposed to H/R in the absence or presence of isoflurane. Cell
cytotoxicity and apoptosis were detected by MTT assay and TUNEL staining, respectively. MPTP function was
monitored by confocal imaging after reoxygenation. ROS production and activation of caspase-3 were determined
by fluorescent reader and western blot, respectively.
Results: As compared to the control group, H/R led to significant cell cytotoxicity and apoptosis, while application
of isoflurane markedly reversed the effects. Furthermore, isoflurane significantly inhibits the formation of
H/R-induced excess ROS production. Finally, isoflurane attenuated the onset of mitochondrial permeability transition
pore (MPTP) occurred during hypoxia/reoxygenation, and in turn inhibited activation of caspase-3.
Conclusions: These data indicate that isoflurane has a protective effect on cardiocytes exposed to H/R by reducing
excess ROS production, blocking open of MPTP and further reducing apoptosis.
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Hypoxia/reperfusion (H/R)-induced cardiocyte injury is
still a clinical problem, particularly after cardiopulmonary
bypass (CPB). The main problem in H/R cardiocyte injury
is myocardial dysfunction, manifested by arrhythmia and
myocardial failure. Volatile anesthetics can protect against
reperfusion injury after myocardial ischemia in vitro and
in vivo [1-4]. Isoflurane is one of the drugs most com-
monly used to maintain the state of general anesthesia. It
has been reported that isoflurane preconditioning can
mimic ischemia preconditioning to protect against reper-
fusion injury after myocardial ischemia in vitro and in vivo
[3,4]. However, to date, the mechanisms of isoflurane con-
ditioning remain unclear. Compelling experimental evi-
dence indicates that reactive oxygen species (ROS) play a* Correspondence: yhfdoctor1@126.com
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Elevated ROS production during reperfusion enhances
Ca2+ influx into mitochondria, opens the mitochondrial
permeability transition pore (MPTP), and in turn contrib-
utes to apoptotic cell death [5]. Previous studies showed
that desflurane improves the resistance of the transition
pore to Ca2+-induced opening after ischemia and reperfu-
sion [6]. In this study, we used primary cultured cardio-
cytes as an in vitro model to investigate the effects of
isoflurane on H/R-induced cardiocyte injury.Methods
Experimental animals
All experiments were performed in accordance with the
protocols approved by Institutional Animal Care and Use
Committee and conformed to the Guide for the Care and
Use of Laboratory Animals of Xuzhou Medical College,
China. This study was approved by the Animal Ethics
Committee of Nanjing Medical University, and was in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Wu et al. BMC Anesthesiology 2014, 14:17 Page 2 of 7
http://www.biomedcentral.com/1471-2253/14/17compliance with the Guide for the Care and Use of
Laboratory Animals published by the Chinese National In-
stitute of Health.
Cardiocyte culture
Neonatal rat Sprague-Dawley hearts (1 ~ 3 days old)
were removed under sterile conditions and washed 3
times in phosphate buffered saline (PBS) to remove ex-
cess blood cells. The ventricles were minced small pieces
and then agitated gently in a solution of 0.125% trypsin.
The mixture was centrifuged at 1000 × g for 10 min. The
supernatant phase was discarded, and the cells were re-
suspended in Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% fetal bovine serum, 100 U/ml
penicillin and 100 μg/ml streptomycin. Isolated cells
were cultured in a flask for 1 h at 37°C in order to re-
move fibroblasts. The suspended cells were diluted to
about 5.0 × 105 cells/ml, and seeded in a 6-well plastic
plate (2 ml for each well). The cultures were incubated
for 72 h in a humidified atmosphere of 5% CO2 and 95%
air at 37°C.
Preparation of isoflurane solution
A stock solution of isoflurane dissolved in culture medium
was prepared using a modification of the method of
Blanck and Thompson [7]. 10 mM isoflurane solution was
made by injecting 130 μl liquid isoflurane (Aerrane, Baxter
Healthcare Corp., USA) into 100 ml PBS in a 100 ml volu-
metric flask. The flask was sealed with a glass stopper to
exclude all air from the neck of the flask. The flask was
wrapped in aluminum foil, and stirred for 24 hours to dis-
solve isoflurane. Immediately before use, 30 ml of the con-
centrated stock solution was poured into a 50 ml
polypropylene centrifuge tube and vortexed for 5 to 10 sec-
onds to produce the working stock. An aliquot of the
working stock was assayed by gas chromatography to de-
termine the concentration of dissolved isoflurane. For
treating cell cultures, the working stock was diluted with
Dulbecco’s modified Eagle’s medium (DMEM) to produce
0.4 mM isoflurane in solution, equivalent to 2.2% atm iso-
flurane (equivalent to 1.8 MAC) equilibrated with aqueous
medium. The stability of isoflurane in solution was deter-
mined by incubating samples of the working stock under
identical conditions used in treating cell cultures for a
period of 30 minutes. Gas chromatography was used to
confirm the concentration of isoflurane.
Hypoxia and reoxygenation
The hypoxic-reoxygenated cultures were placed within a
modular incubator chamber (Thermo, USA), filled with
1% O2, 5% CO2, and balanced N2 for 3 h, then 21% oxygen
for 2 h. For hypoxia, the culture media were replaced by a
modified Tyrode’s solution [8] (in mM/l: 136.9 NaCl, 2.68
KCl, 8.1 Na2HPO4 · 12 H2O, 1.47 KH2PO4, 0.9 CaCl2, and0.49 MgCl2 · 6 H2O; pH 7.4). Control cultures were con-
tinuously incubated in 5% CO2 and 95% air at 37°C.
Cardiocytes were randomly divided into 4 groups: 1)
Control group, cardiocytes were incubated at 37°C in a
humidified atmosphere of 5% CO2 and 95% air for 5 hours;
2) hypoxia/reoxygenation group, cardiocytes were exposed
to hypoxia (1% O2 and 5% CO2 ) for 3 hr followed by 2 hr
reoxygenation (95% air and 5% CO2 ); 3) Isoflurane with
hypoxia/reoxygenation group, 3 hr hypoxia followed by
2 hr reoxygenation, isoflurane (0.4mΜ) solution was
added in medium during hypoxia; 4) Isoflurane without
hypoxia/reoxygenation group, cardiocytes were incubated
under a condition similar to control group in the presence
of isoflurane. Calcein imaging was performed after hyp-
oxia for 3 hr followed by 50 min reoxygenation due to the
better imaging effect at that time.
MTT assay
The cell suspensions were diluted to a concentration
of ~ 5 × 104 cells/ml. A 100 μl aliquot containing ~5 × 103
cells was added immediately to each well of a 96-well flat
bottom microplate in sextuplet. After a period of 72 h incu-
bation at 37°C in 5% CO2, the cultures were subjected to
hypoxia/reoxygenation. Isoflurane solution (Baxter, USA)
was added to the wells at final concentration of 0.4mΜ.
Cardiocyte Cytotoxicity was assayed with a MTT (3-4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
cell proliferation and cytotoxicity assay kit (Beyotime,
Shanghai, China). The absorbance was determined at a
wave length of 492 nm using an ELISA reader as the
cardiocyte-cytotoxicity value [9].
TUNEL labeling
Terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNEL) was used to assess cardiocyte
apoptosis in this study [10]. The cultures were analyzed
for apoptotic DNA fragmentation by using the One Step
TUNEL Apoptosis Assay Kit (Beyotime, Shanghai, China).
dUTP conjugated with fluorescein isothiocyanate (FITC)
labels the 3'-OH terminal of the DNA strand breaks,
which was catalyzed by Terminal deoxynucleotidyl trans-
ferase. Cardiocytes incubated in 6-well microplates for
72 h were washed with PBS and fixed in 4% paraformalde-
hyde for 30 min. After washed with PBS, the cells were in-
cubated with cold PBS containing 0.1% Triton X-100 for
2 min in a dark condition. Following PBS wash, the cells
were incubated with a TUNEL reaction buffer for 1 h at
37°C in a humidified chamber away from light. The cul-
tures were finally washed with PBS three times, Fluores-
cence was detected with emission wavelength at 530 nm
and excitation wavelength at 485 nm using a laser scan-
ning confocal microscope (LSCM, Leica, Germany), and
the fluorescence intensity of FITC was analyzed with
Image-Pro plus 6.0 software.
Figure 1 Viability value of each group (n = 6). *p < 0.01, compared
to the control group; # p < 0.01, compared to the H/R group. Con,
control; H/R, hypoxia/reoxygenation; Iso + H/R, isoflurane plus H/R; Iso,
isoflurane alone. The concentration of isoflurane was 0.4 mM.
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Calcein-AM is permeable to the mitochondria, and is de-
esterified and trapped in the matrix space in its free fluor-
escent form (calcein). Therefore, after cold ester loading/
warm incubation, most calcein-AM localized exclusively
to mitochondria. Calcein leaks from the mitochondria
when MPTP opens. As a result, calcein fluorescence de-
creases in the mitochrondria, and redistributes to the
cytosol and nucleus [11]. Myocytes were loaded with
Calcein-AM (1 μM) for 30 min at 4°C in HEPES-buffered
Dulbecco's modified eagle medium (DMEM, 20 mM
HEPES) containing 10% fetal calf serum at pH 7.4. After
cold loading, cells were further incubated for 5 h at 37°C
in DMEM without serum. Prior to mounting on the
microscope, cells were washed twice with PBS [12]. Fluor-
escence was detected with emission wavelength at 515 nm
and excitation wavelength at 490 nm using a laser scan-
ning confocal microscope (LSCM, Leica, Germany).
Western blot
After treatment, samples were collected in 40 ml of SDS
sample buffer (10 mM Tris-HCl buffer, pH 6.8, 2% sodium
dodecylsulfate, 10% glycerol, 0.01% bromophenol blue and
5% β-mercaptoethanol), and boiled at 100°C for 5 min.
The extracts were separated by 20% SDS-PAGE, trans-
ferred to nitrocellulose membranes, and blocked with 5%
non-fat milk in PBS-T (PBS, 0.1% Triton X-100) for 1 hr
at room temperature. The membranes were then incu-
bated with primary antibodies against cleaved caspase-3
(1:1000, Cell signaling) in PBS-T overnight at 4°C. Follow-
ing incubation with horseradish peroxidase-conjugated
goat anti-rabbit antibodies (1:5000; Pierce, Rockford, IL,
USA), the signals were detected by the chemiluminescence
method (SuperSignal West Pico, Pierce, Rockford, IL,
USA). For the purpose of normalization, the membranes
were stripped, and re-probed with antibodies against β-
actin (1:10,000; Sigma, St Louis, MO, USA). Several expo-
sures were used to obtain signals in the linear range. The
bands were quantified by using Image-Pro plus 6.0
software.
Measurement of ROS
Measurement of ROS production was performed as de-
scribed previously with slight modifications [13]. Briefly,
cells growing in 6 well plates at a density of about 5 × 105/
well, in the presence or absence of isoflurane precondi-
tioning, were loaded with 5 μM DCFH-DA (Molecular
Probe, Eugene, USA) diluted in PBS buffer and incubated
for 30 minutes. DCFH-DA penetrated into the cytoplasm,
and was converted to 2’,7’-dichlorofluorescin (DCFH) by
the hydroxylation of cellular esterase. Oxidation of DCFH
by hydrogen peroxide and hydroxyl radicals generates a
fluorescent product, 2’,7’-dichlorofluorescein (DCF). The
intensity of DCF fluorescence was determined by aChameleon multi-label plate reader (Hidex Personal Life
Science, Finland), with an excitation wavelength of
450 nm and an emission wavelength of 535 nm. The rela-
tive fluorescence intensity was expressed as a percentage
of the control group.Statistical analysis
Data were expressed as mean ± SD. One-way ANOVA
followed by the post hoc (SNK) test was used to deter-
mine significant differences among all groups. P values
less than 0.05 were considered to be significant.Results
Isoflurane attenuates hypoxia/reperfusion-induced
cell cytotoxicity
MTT assay was used to detect the cardiocyte cytotoxicity
reaction. The absorbance analyzed at 492 nm with ELISA
reader is shown in Figure 1. As compared to the control
group, hypoxia/reperfusion significantly reduced the value
of absorbance (0.417 ± 0.006 versus 0.442 ± 0.010, p < 0.01),
indicating its induction of cytotoxicity. There was a signifi-
cant difference in absorbance between hypoxia/reperfusion
and isoflurane group (0.417 ± 0.006 versus 0.462 ± 0.011,
p < 0.01), suggesting that addition of isoflurane markedly re-
versed the toxic effect of hypoxia/reperfusion. Additionally,
the isoflurane alone group (without hypoxia/reperfusion) did
not display a significant difference as compared to the
control group (0.437 ± 0.008 versus 0.442 ± 0.010, p < 0.05).
These results suggest that isoflurane attenuates cell cytotox-
icity triggered by hypoxia/reperfusion.
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cardiocyte apoptosis
It is known that hypoxia/reperfusion can induce signifi-
cant cardiocyte apoptosis, thus we further wanted to know
if isoflurane prevent cardiocytes from the apoptosis. As
shown in Figure 2, by using TUNEL staining, exposure of
cardiocytes to hypoxia/reoxygenation caused a significant
increase in apoptosis as compared with the control group
(p < 0.01). Additionally, isoflurane itself did not lead to any
significant change in apoptosis (Figure 2). Together, in
agreement with cytotoxicity data, addition of isoflurane to
cultured cardiocytes greatly attenuated hypoxia/reoxygen-
ation-induced cardiocyte apoptosis.Figure 2 Effects of isoflurane on H/R-induced apoptosis shown
by TUNEL labeling. Top panel, representative images; Bottom
panel, quantification of fluorescence intensity (cells were randomly
selected from different areas; each value was from three separate
experiments). Con, control (n = 34); H/R, hypoxia/reoxygenation
(n = 38); Iso + H/R, isoflurane plus H/R (n = 40); Iso, isoflurane alone
(n = 36). *p < 0.01, compared to the control group; # p < 0.01,
compared to the H/R group. Scale bar, 50 μm.Isoflurane prevents opening of MPTP
Previous studies indicate that opening of the mitochon-
drial permeability transition pore (MPTP) is associated
with cardiocyte apoptosis occurred during cardiocyte re-
perfusion injury, thus we wondered if isoflurane protects
cardiocytes by preventing MPTP opening. To reveal dir-
ectly opening of the MPTP after reperfusion, we imaged
calcein by confocal microscopy. As shown in Figure 3A, in
the cardiocyte of the control group, when 30 minutes of
cold ester loading was followed by 5 hours of warm incu-
bation, fluorophore loading appeared to be exclusively
confined to the mitochondria. In contrast, when cardio-
cytes were subjected to hypoxia/reoxygenation at pH 7.4
(Figure 3B), calcein fluorescence was released from mito-
chondria and redistributed to the cytosol and nucleus.
When isoflurane was added during hypoxia/reoxgenation
(Figure 3C), the redistribution were significantly attenu-
ated. Isoflurane alone did not change the redistribution
(Figure 3D). These findings suggest that isoflurane pre-
vents MPTP opening during hypoxia/reoxygenation.
Isoflurane inhibits hypoxia/reperfusion-induced activation
of caspase-3
MPTP opening will initiate the apoptotic pathways.
Downstream activation of caspase-3, a key enzyme to
execution stage of the apoptotic pathway, plays a vital
role in apoptosis. Next, we examined activation of
caspase-3 following hypoxia/reperfusion by western
blot. As seen in Figure 4, exposure of cardiocytes toFigure 3 Isoflurane prevents MPTP opening of cultured
cardiocytes exposed to hypoxia/reperfusion. Representative
images of single cardiomyocytes from the four different groups are
shown. (A) Con, control; (B) H/R, hypoxia/reoxygenation; (C) Iso + H/R,
isoflurane plus H/R; (D) Iso, isoflurane alone. The fluorescent dots indicate
mitochondria; the arrow indicates the nucleus. Scale bar, 10 μm.
Figure 4 Isoflurane inhibits activation of caspase-3. Samples
were collected after cardiocytes were differently treated. The level of
cleaved caspase-3 and β-actin were examined by Western blot. The
signal of cleaved caspase-3 Asp175 was quantified and normalized to
β-actin. Top panel, representative blots; Bottom panel, quantification of
relative activated caspase-3 level to the control group. Data were
collected from three independent preparations for each group.
*p < 0.01, compared to the control group; # p < 0.01, compared to
the H/R group. Con, control; H/R, hypoxia/reoxygenation; Iso + H/R,
isoflurane plus H/R; Iso, isoflurane alone.
Figure 5 Isoflurane prevent the formation of H/R-induced ROS
production. Samples were collected after cardiocytes were
differently treated and loaded with 5 μM DCFH-DA. The intensity of
DCF fluorescence was determined by a Chameleon multilabel
plate reader. The relative fluorescence intensity was expressed as a
percentage of the control group. Data were collected from three
independent preparations for each group. *p < 0.01, compared to
the control group; # p < 0.01, compared to the H/R group. Con,
control; H/R, hypoxia/reoxygenation; Iso + H/R, isoflurane plus H/R;
Iso, isoflurane alone.
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level of the large fragment (cleaved caspase-3 at Asp175) of
activated caspase-3. In the presence of isoflurane, the
endogenous level of the cleaved caspase-3 was greatly
down-regulated. Isoflurane itself appeared not to affect the
activation of caspase-3 (Figure 4). These results suggest that




It is well-known that excess ROS production is regarded as
an initial cause of H/R injury [14]. As major sites of ROS
production, the mitochondria play a key role in ROS-
related injury. We wondered if isoflurane pretreatment pre-
vents the formation of reactive oxygen species (ROS)
production induced by H/R. As many studies showed, we
observed that H/R triggered a significant increase in the
ROS level when compared to the control group (Figure 5).
Isoflurane preconditioning substantially decreased the level
of ROS production (Figure 5). Interestingly, the level was
still higher than the control group, suggesting that the
proper ROS production may improve cardiocyte survival.
Additionally, we also observed that isoflurane at 0.4 mM it-
self did not influence the formation of ROS production
(Figure 5). Together, the results point to the inhibitory role
of isoflurane in H/R-induced ROS formation.Discussion
This study was designed to investigate the effects of iso-
flurane on cultured cardiocytes exposure to H/R. Our
data suggest that: 1) isoflurane pretreatment significantly
attenuates the cardiocyte apoptosis induced by H/R; 2)
Isoflurane pretreatment prevents formation of excess
ROS production, attenuates MPTP opening, and in turn
inhibits activation of caspase-3.
Previous studies showed that volatile anesthetics isoflur-
ane preconditioning can protect against reperfusion injury
following myocardial ischemia in vitro and in vivo [3,4].
Compared to other volatile anesthetics, for example sevo-
flurane and desflurane, isoflurane showed a more powerful
potency to reduce myocardial infarct size in experimental
animals with preconditioning paradigm [15]. In line with
our in vitro results, isoflurane-treated mice which were
subjected to ischemia followed by 2 weeks of reperfusion
exhibited reduction of expression of cleaved caspase-3 and
TUNEL staining [16].
The key roles of mitochondria in isoflurane-induced
cardioprotection are well established. The potential
mechanisms involves PKC translocation to mitochon-
dria, phosphorylation of aldehyde dehydrogenase 2
(ALDH2), mitochondrial depolarization, matrix acidifi-
cation, MPTP, mitochondrial Ca2+ homeostasis, mito-
chondrial KATP channels and so on [17-19]. Opening of
MPTP is related to mitochondrial damage, and further
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observed the inhibitory role of isoflurane pretreatment in
H/R-induced opening of MPTP by the confocal imaging,
supporting previous research results [20]. Because the
mitochondria are major sites of ROS generation, we fur-
ther observed that H/R-induced excess ROS production
was prevented in the presence of isoflurane, supporting a
link of excess ROS formation as an upstream signal to
MPTP opening. Intriguingly, the protective role of isoflur-
ane appeared to be associated with a proper level of ROS
generation. Consistently, increased ROS production (com-
pared to the control experiments) following isoflurane in-
halation caused a tolerance against myocardial infarction
in vivo [21,22]. Together, the beneficial effect of isoflurane
is at least in part achieved by adjusting excess ROS pro-
duction to a proper level during H/R.
Opening of the MPTP is related to swelling and un-
coupling of mitochondria as occurs in damaged tissues by
reperfusion injury [23]. The swelling of the mitochondria
appears to be sufficient to activate caspases and thus in-
duce apoptosis [24]. In our study, we focused on the effect
of isoflurane on opening of MPTP, and clearly observed
that isoflurane decreased the opening of MPTP, and inhib-
ited activation of its downstream caspase-3. In agreement
with our results, a previous in vivo report showed that iso-
flurane post-conditioning prevented opening of MPTP,
and as a result protected mouse hearts from reperfusion
injury [25]. Though using a different paradigm (post-con-
ditioning versus preconditioning), common mechanisms
may be shared. In support, another report showed a key
role of cytochrome c release from the mitochondria in the
pathogenesis of ischemia/reperfusion injury by examining
cytochrome c in the mitochondria and cytosol, suggesting
that the myocardioprotective effects of isoflurane precon-
ditioning were associated with inhibition of cytochrome c
loss from mitochondria [26]. Therefore, preventing MPTP
opening is central to myocardioprotection induced by iso-
flurane pretreatment.
Conclusions
The volatile anesthetic isoflurane pretreatment protects
against cardiocyte ischemia and reperfusion injury by mul-
tiple mechanisms. Our findings suggest that isoflurane has
protective effects on cardiocytes exposed to H/R by pre-
venting ROS formation, blocking MPTP opening and fur-
ther reducing activation of apoptotic protein caspase-3.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WW: performed the experiments, collected and analyzed data, and wrote the
manuscript. XZ: collected and analyzed data, and wrote the manuscript. PL
WF and LL: collected and analyzed data. HY: designed and supervised this
study, analyzed and explained data, as well as wrote the manuscript. All
authors read and approved the final manuscript.Authors’ information
This work was supported by Department of Anesthesiology, Changzhou
NO.2 People’s Hospital.
Author details
1Department of Anesthesiology, Changzhou No.2 People’s Hospital, the
affiliated hospital of Nanjing Medical University, Changzhou 213003, China.
2Department of Neurology, Changzhou No.2 People’s Hospital, the affiliated
hospital of Nanjing Medical University, Changzhou 213003, China.
Received: 23 September 2013 Accepted: 3 March 2014
Published: 10 March 2014
References
1. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Is
isoflurane-induced preconditioning dose related? Anesthesiology 2002,
96:675–680.
2. Obal D, Preckel B, Scharbatke H, Müllenheim J, Höterkes F, Thämer V,
Schlack W: One MAC of sevoflurane provides protection against
reperfusion injury in the rat heart in vivo. Br J Anaesth 2001, 87:905–911.
3. Martini N, Preckel B, Thämer V, Schlack W: Can isoflurane mimic ischemia
preconditioning in isolated rat? Br J Anaesth 2001, 86:269–271.
4. Raphael J, Zuo Z, Abedat S, Beeri R, Gozal Y: Isoflurane preconditioning
decreases myocardial infarction in rabbits via up-regulation of hypoxia
inducible factor 1 that is mediated by mammalian target of rapamycin.
Anesthesiology 2008, 108(3):415–425.
5. Kim JS, Jin Y, Lemasters JJ: Reactive oxygen species, but not Ca2+
overloading, trigger pH and mitochondrial permeability transition-
dependent death of adult rat myocytes after ischemia-reperfusion. Am J
Physiol Heart Circ Physiol 2006, 290:2024–2034.
6. Bienengraeber MW, Weihrauch D, Kersten JR, Pagel PS, Warltier DC:
Cardioprotection by volatile anesthetics. Vasc Pharmacol 2005,
42:243–252.
7. Wise-Faberowski L, Pearlstein RD, Warner DS: NMDA-induced apoptosis in
mixed neuronal/glial cortical cell cultures: the effects of isoflurane and
dizocilpine. J Neurosurg Anesthesiol 2006, 18:240–246.
8. Wang GW, Zhou Z, Klein JB, Kang YJ: Inhibition of hypoxia/reoxygenation-
induced apoptosis in metallothionein- overexpressing cardiomyocytes.
Am J Physiol Heart Circ Physiol 2001, 280:2292–2299.
9. Li QT, Zhu YZ, Chu JY, Dong K, He P, Feng CY, Hu BY, Zhang SM, Guo XK:
Granulocyte-macrophage colony-stimulating factor DNA prime-protein
boosts strategy to enhance efficacy of a recombinant pertussis DNA
vaccine. Acta Pharmacol Sin 2006, 27(11):1487–1494.
10. Wise-Faberowski L, Raizada MK, Sumners C: Oxygen and glucose
deprivation-induced neuronal apoptosis is attenuated by halothane and
isoflurane. Anesth Analg 2001, 93:1281–1287.
11. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F: Mitochondria and
cell death. Mechanistic aspects and methodological issues. Eur J Biochem
1999, 264:687–701.
12. Trollinger DR, Cascio WE, Lemasters JJ: Selective loading of Rhod 2 into
mitochondria shows mitochondrial Ca2+ transients during the contractile
cycle in adult rabbit cardiac myocytes. Biochem Biophys Res Comm 1997,
236:738–742.
13. Wei H, Leeds P, Chen RW, Wei W, Leng Y, Bredesen DE, Chuang DM:
Neuronal apoptosis induced by pharmacological concentrations of
3-hydroxykynurenine:characterization and protection by dantrolene and
Bcl-2 overexpression. J Neurochem 2000, 75:81–90.
14. Vanden Hoek TL, Shao Z, Li C, Schumacker PT, Becker LB: Mitochondrial
electron transport can become a significant source of oxidative injury in
cardiomyocytes. J Mol Cell Cardiol 1997, 29(9):2441–2450.
15. Redel A, Stumpner J, Tischer-Zeitz T, Lange M, Smul TM, Lotz C, Roewer N,
Kehl F: Comparison of isoflurane-, sevoflurane-, and desflurane-induced
pre- and postconditioning against myocardial infarction in mice in vivo.
Exp Biol Med 2009, 234:1186–1191.
16. Tsutsumi YM, Patel HH, Lai NC, Takahashi T, Head BP, Roth DM: Isoflurane
produces sustained cardiac protection after ischemia-reperfusion injury
in mice. Anesthesiology 2006, 104:495–502.
17. Pravdic D, Hirata N, Barber L, Sedlic F, Bosnjak ZJ, Bienengraeber M:
Complex I and ATP synthase mediate membrane depolarization and
matrix acidification by isoflurane in mitochondria. Eur J Pharmacol 2012,
690(1–3):149–157.
Wu et al. BMC Anesthesiology 2014, 14:17 Page 7 of 7
http://www.biomedcentral.com/1471-2253/14/1718. Lang XE, Wang X, Zhang KR, Lv JY, Jin JH, Li QS: Isoflurane preconditioning
confers cardioprotection by activation of ALDH2. Plos One 2013, 8(2):e52469.
19. Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR,
Pagel PS: Inhibition of mitochondrial permeability transition enhances
isoflurane-induced cardioprotection during early reperfusion: the role of
mitochondrial KATP channels. Anesth Analg 2005, 101(6):1590–1596.
20. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ:
Anesthetic-induced preconditioning delays opening of mitochondrial
permeability transition pore via protein Kinase C-epsilon-mediated
pathway. Anesthesiology 2009, 111(2):267–274.
21. Tanaka K, Weihrauch D, Kehl F, Ludwig LM, LaDisa JF Jr, Kersten JR, Pagel PS,
Warltier DC: Mechanism of preconditioning by isoflurane in rabbits: a direct
role for reactive oxygen species. Anesthesiology 2002, 97(6):1485–1490.
22. Müllenheim J, Ebel D, Frässdorf J, Preckel B, Thämer V, Schlack W: Isoflurane
preconditions myocardium against infarction via release of free radicals.
Anesthesiology 2002, 96(4):934–940.
23. Reimer KA, Jennings RB: Myocardial ischemia, hypoxia and infarction. In
The Heart and Cardovascular System. Secondth edition. Edited by Fozzard
HA, Jennings RB, Huber E, Katz AM, Morgan HE. NewYork: Raven Press Ltd;
1992:1875–1973.
24. Halestrap AP, Kerr PM, Javadov S: The mitochondrial permeability
transition: role in ischemia/reperfusion injury. Sepsis 1998, 2:313–325.
25. Ge ZD, Pravdic D, Bienengraeber M, Pratt PF Jr, Auchampach JA, Gross GJ,
Kersten JR, Warltier DC: Isoflurane postconditioning protects against
reperfusion injury by preventing mitochondrial permeability transition
by an endothelial nitric oxide synthase-dependent mechanism.
Anesthesiology 2010, 112(1):73–85.
26. Qian LP, Zhu SS, Cao JL, Zeng YM: Isoflurane preconditioning protects
against ischemia-reperfusion injury partly by attenuating cytochrome c
release from subsarcolemmal mitochondria in isolated rat hearts.
Acta Pharmacol Sin 2005, 26(7):813–820.
doi:10.1186/1471-2253-14-17
Cite this article as: Wu et al.: Isoflurane reduces hypoxia/reoxygenation-
induced apoptosis and mitochondrial permeability transition in rat primary
cultured cardiocytes. BMC Anesthesiology 2014 14:17.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
